|
|
 | | | |
- close
- close
- close
- close
FiercePharma
Apr 30
Comment
Novartis is doing a complete U-turn on an OTC plant in Switzerland that 18 months ago was going to get the old heave-ho along with the people who worked there. Now the drugmaker says it will invest €150 million in the facility and anoint it a...
Wall Street Journal
Apr 30
Comment
The auction of Brazilian drug maker Aché, which has drawn the interest of Novartis and Abbott Laboratories, has stalled because of a disagreement among the company's family owners.
Market Intelligence Center
Apr 30
Comment
Novartis AG (NYSE: NVS) closed Monday's trading session at $73.74. In the past year, the stock has hit a 52-week low of $51.20 and 52-week high of $74.22. Novartis AG (NVS) stock has been showing support around $73.39 and resistance in the $74.19...
FiercePharma
Apr 29
Comment
It's not often that the U.S. Justice Department delivers a one-two punch against a Big Pharma company. And it isn't often that prosecutors get to use the word "Hooters" in a legal complaint. But that's just what happened last week, when the feds...
Benzinga
Apr 29
Comment
Incyte Corporation (NASDAQ: INCY) announced today that it has earned a $25.0
million milestone payment from Novartis based on the formal initiation of a
Phase II clinical trial evaluating c-MET inhibitor INC280 (formerly INCB28060)
as monotherapy...
Stock Blog Hub
Apr 27
Comment
The US Food and Drug Administration (FDA) recently released briefing documents ahead of the review by its Pulmonary-Allergy Drugs Advisory Committee of the New Drug Application (NDA) of Theravance/Glaxo’s (THRX/GSK) candidate FF/VI...
Forbes
Apr 27
Comment
Twice this past week, the US Department of Justice filed lawsuits alleging Novartis paid kickbacks to boost prescriptions and caused federal healthcare programs to pay for medicines based on false claims. One complaint seeks damages and civil...
New York Times
Apr 27
Comment
The government joined a whistle-blower lawsuit that said a unit of Novartis paid millions to doctors in exchange for prescribing its drugs.
Wall Street Journal
Apr 26
Comment
Federal prosecutors accused the U.S. unit of Novartis of paying kickbacks and providing lavish dinners to doctors to encourage them to prescribe their brand-name drugs to treat hypertension and other maladies.
FiercePharma
Apr 26
Comment
Sanofi ($SNY) is not very popular among its peers today. Its decision last year to halve the cost of its colon cancer drug Zaltrap in the face of high-profile criticism has inspired more than a 100 top docs from around the world to protest the...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
| |||||||
